Zobrazeno 1 - 10
of 318
pro vyhledávání: '"Breakthrough Therapy"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Objective:Since 2016, China has successively implemented Accelerated Drug Marketing Registration Procedures (ADMRPs) for drugs, including Breakthrough Therapy Drug (BTD), Conditional Approval (CA), and Priority Review and Approval (PRA), which have p
Externí odkaz:
https://doaj.org/article/12dee75cd05341749e46fe7f85fb06f3
Autor:
Kainat Riaz, Sejal Suneel, Mohammad Hamza Bin Abdul Malik, Tooba Kashif, Irfan Ullah, Abdul Waris, Marco Di Nicola, Marianna Mazza, Gabriele Sani, Giovanni Martinotti, Domenico De Berardis
Publikováno v:
Diseases, Vol 11, Iss 4, p 159 (2023)
Post-traumatic stress disorder (PTSD) is a debilitating mental health disorder that causes significant dysfunction in individuals. Currently, there are many approved pharmacotherapy and psychotherapy treatment options for PTSD, but unfortunately, hal
Externí odkaz:
https://doaj.org/article/82d29bf2b0e4475bbef1cd0dd2a20a3f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Pharmacy, Vol 10, Iss 5, p 126 (2022)
The “breakthrough therapy” designation (BTD) is a recent mechanism implemented by the United States Food and Drug Administration (FDA) to expedite access to drugs that address unmet needs. The purpose of this study is to describe pharmacists’ k
Externí odkaz:
https://doaj.org/article/b2abf1533abf41538e51420033718df7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Allison A. Feduccia, Lisa Jerome, Berra Yazar-Klosinski, Amy Emerson, Michael C. Mithoefer, Rick Doblin
Publikováno v:
Frontiers in Psychiatry, Vol 10 (2019)
Unsuccessfully treated posttraumatic stress disorder (PTSD) is a serious and life-threatening disorder. Two medications, paroxetine hydrochloride and sertraline hydrochloride, are approved treatments for PTSD by the Food and Drug Administration (FDA)
Externí odkaz:
https://doaj.org/article/bbc8da2e6ec14e4dad855df8de1cb03d
Autor:
Law, Benson
Publikováno v:
Electronic Thesis and Dissertation Repository
The objective of this retrospective critical appraisal study was to determine if the trials submitted to the Food and Drug Administration for the expedited approval of pimavanserin was of sufficient methodological quality to ascertain its safety and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1548::b5a2392d85c7f34965d279a92c3b4330
https://ir.lib.uwo.ca/context/etd/article/12043/filename/1/type/additional/viewcontent/Supplementary_File_B___ROB_2.xlsm
https://ir.lib.uwo.ca/context/etd/article/12043/filename/1/type/additional/viewcontent/Supplementary_File_B___ROB_2.xlsm
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Neurochemistry. 162:24-38
A confluence of factors has renewed interest in the scientific understanding and translational potential of psychedelic drugs such as lysergic acid diethylamide (LSD), mescaline, and psilocybin: the desire for additional approaches to mental health c
Publikováno v:
Journal of Neurochemistry. 162:89-108
The studies of psychedelics, especially psychedelic tryptamines like psilocybin, are rapidly gaining interest in neuroscience research. Much of this interest stems from recent clinical studies demonstrating that they have a unique ability to improve